Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination

Journal of Infectious Diseases

Volumn 201, Issue 10, 2010, Pages 1535-1543

  Grassly, Nicholas C ^c   Jafari, Hamid ^a   Bahl, Sunil ^a   Durrani, Sunita ^a   Wenger, Jay ^a,b   Sutter, Roland W ^a   Bruce Aylward, R ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ARTICLE; CHILD; CONTROLLED STUDY; DRUG DOSE COMPARISON; FECES ANALYSIS; HUMAN; INDIA; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; POLIOMYELITIS; POLIOMYELITIS VIRUS 1; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; VIRUS EXCRETION; VIRUS ISOLATION; VIRUS TRANSMISSION; WILD TYPE; CLASSIFICATION; DISEASE TRANSMISSION; FECES; IMMUNOLOGY; INFANT; NEWBORN; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; VIROLOGY;

CHILD, PRESCHOOL; FECES; HUMANS; INDIA; INFANT; INFANT, NEWBORN; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL;

EID: 77951918630     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/651952     Document Type: Article

References (28)

1. Sutter RW, Kew OM, Cochi SL. Poliovirus vaccine- live. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia, PA: Saunders, 2004: 651-705.
2. World Health Organisation. Progress towards interrupting wild poliovirus transmission worldwide, January 2007-April 2008. Wkly Epidemiol Rec 2008; 83: 170-176.
3. Ghendon YZ, Sanakoyeva II. Comparison of the resistance of the intestinal tract to poliomyelitis virus (Sabin's strains) in persons after naturally and experimentally acquired immunity. Acta Virol 1961; 5: 265-273.
4. Sutter RW, Suleiman AJM, Malankar P, et al. Trial of a supplemental dose of four poliovirus vaccines. New Engl J Med 2000; 343: 767-773.
5. World Health Organization Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. J Infect Dis 1997; 175(suppl 1): S215-S227.
6. du Chatelet IP, Merchant AT, Fisher-Hoch S, et al. Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules. Vaccine 2003; 21: 1710-1718.
7. Laassri M, Lottenbach K, Belshe R, et al. Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains. J Infect Dis 2005; 192: 2092-2098.
8. Modlin JF, Halsey NA, Thoms ML, Meschievitz CK, Patriarca PA. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine - live attenuated oral poliovirus vaccine immunization schedules. J Infect Dis 1997; 175: S228-S234.
9. Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines. J Infect Dis 1991; 163: 1-6.
10. Henry JL, Jaikaran ES, Davies JR, et al. A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine. J Hyg (Lond) 1966; 64: 105-120.
11. Swartz TA, Green MS, Handscher R, et al. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel. Vaccine 2008; 26: 1083-1090.
12. Grassly NC, Wenger J, Durrani S, et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. Lancet 2007; 369: 1356-1362. (Pubitemid 46613904)
13. Indian Council for Medical Research. Prevalence of poliovirus antibodies in Moradabad, India: preliminary report. New Delhi, India: Indian Council for Medical Research and National Polio Surveillance Project, 2008.
14. World Health Organization. Conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication, November 2008. Wkly Epidemiol Rec 2009; 84: 17-28.
15. Grassly NC, Jafari H, Bahl S, et al. Mucosal immunity following vaccination with monovalent and trivalent oral poliovirus vaccines in India. J Infect Dis 2009; 200: 794-801.
16. Sutter RW, Patriarca PA, Brogan S, et al. Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet 1991; 338: 715-720.
17. Banerjee K, Hlady WG, Andrus JK, Sarkar S, Fitzsimmons J, Abeykoon P. Poliomyelitis surveillance: the model used in India for polio eradication. Bull WHO 2000; 78: 321-329.
18. Ministry of Health and Family Welfare. field guide: surveillance of acute flaccid paralysis. New Delhi, India: Child Health Division, Department of Family Welfare, Ministry of Health and Family Welfare, 2005.
19. World Health Organisation. Progress towards poliomyelitis eradication: India, January 2006-September 2007. Wkly Epidemiol Rec 2007; 82: 402-407.
20. Gelfand HM, LeBlanc DR, Fox JP, Conwell D. Studies on the development of natural immunity to poliomyelitis in Louisiana II. Description and analysis of infection observed in study group households. AmJ Hyg 1957; 65: 367-385.
21. Dowdle WR. Influenza pandemic periodicity, virus recycling, and the art of risk assessment. Emerg Infect Dis 2006; 12: 34-39.
22. Gomes MGM, White LJ, Medley GF. Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives. J Theor Biol 2004; 228: 539-549.
23. Hatch LA, Hughes KE, Pilford JN. Observations on the excretion of type 1 poliovirus from cases and their contacts. Am J Med Sci 1958; 236: 419-1124
24. Marine WM, Chin TDY, Gravelle CR. Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children: a family study during a type 1 poliomyelitis epidemic. Am J Hyg 1962; 76: 173-195.
25. Alexander JP Jr, Gary HE Jr, Pallansch MA. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis 1997; 175(suppl 1): S176-S182.
26. Grassly NC, Fraser C, Wenger J, et al. New strategies for the elimination of polio from India. Science 2006; 314: 1150-1153.
27. Krugman S, Warren J, Eiger MS, Berman PH, Michaels RM and Sabin AB. Immunization with live attenuated poliovirus vaccine. Am J Dis Child 1961; 101: 23-29.
28. Casey AE. The incubation period in epidemic poliomyelitis. J Am Med Assoc 1942; 120: 805-807.